Tower Research Capital LLC (Trc) Abvc Biopharma, Inc. Transaction History

Tower Research Capital LLC (Trc)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.5 - $0.92 $312 - $575	625 Added 4.72%	13,879 $7,000
Q1 2023 May 09, 2023	SELL	$0.57 - $1.07 $566 - $1,063	-994 Reduced 6.98%	13,254 $8,000
Q4 2022 Feb 10, 2023	SELL	$0.62 - $9.1 $527 - $7,735	-850 Reduced 5.63%	14,248 $9,000
Q3 2022 Nov 10, 2022	BUY	$0.52 - $8.9 $4,732 - $80,998	9,101 Added 151.76%	15,098 $13,000
Q2 2022 Aug 15, 2022	BUY	$0.9 - $2.93 $5,397 - $17,571	5,997 New	5,997 $6,000
Q4 2021 Feb 14, 2022	SELL	$2.15 - $6.03 $7,507 - $21,056	-3,492 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.03 - $5.1 $7,088 - $17,809	3,492 New	3,492 $8,000

Ticker ABVC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,632,300
Market Cap $22.8M
Description
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major dep...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.